Although the functions of most metabolites in tumors remain unclear, our findings suggest that MDH2, as a mitochondrial metabolic enzyme, substantially alters the metabolic pattern of cancer cells and influences tumor progression. The gene discussed is MDH2; the disease is neoplasm.